common glp 1 agonists Frontiers America's Poison Centers - GLP-1

doi: 10.3389/fphar.2025.1675552 Received 29 July 2025 Accepted 28 August 2025 Published 11 September 2025 Volume 16 - 2025 Edited by Claudia Manca, University of Cagliari, Italy Reviewed by Basveshwar Gawali, Washington University in St

By activating GLP-1 receptors, these drugs enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and influence central appetite signaling

[1] [12] Additionally, GLP-1 receptor agonists slow gastric emptying and act on appetite centres in the brain, promoting satiety and reducing food intake

The IFP consists of adipocytes and is highly innervated and vascularized